MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation

EQS-News: MorphoSys AG / Key word(s): ConferenceMorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting 24.04.2024 / 16:40 CET/CESTThe issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, April...

Related Keywords

Massachusetts ,United States ,Boston ,Illinois ,Germany ,Chicago ,Planegg ,Bayern ,American ,Kaitlyn Nealy ,Julia Neugebauer ,Thomas Biegi ,Twitter ,American Society Of Clinical Oncology ,Nasdaq ,Lymphoma Society ,Constellation Pharmaceuticals Inc ,Distribution Services ,Linkedin ,Corporate Affairs ,Sys To Present New Phase ,Oral Presentation ,Clinical Oncology ,Efficacy Data ,Combination With Ruxolitinib ,Patients With ,Advanced Solid Tumors ,Vice President ,Global Head ,Corporate News ,Regulatory Announcements ,